Mednet Logo
HomeEndocrinology
Endocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

What range of musculoskeletal complaints have you seen with romosozumab use?

1 Answers

Mednet Member
Mednet Member
General Internal Medicine · University of New Mexico Health Sciences Center

The most common side effect with Romo is injection site reactions. Some patients may have musculoskeletal pain but so do many patients not on Romo. Overall, I found that it is very well tolerated, but if a patient believes that it is causing major undesirable effects, then it is probably best to sto...

Does vitamin D supplementation in primary hyperparathyroidism increase the risk of kidney stones?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

Hyperparathyroidism does increase the risk of developing kidney stones. A study in New England Journal of Medicine, Broadus et al., PMID 7351950, reported that patients with elevated concentrations of 1,25-dihydroxyvitamin D are at increased risk for kidney stones. The reason is that 1,25-dihydroxyv...

Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?

1 Answers

Mednet Member
Mednet Member
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

Hypersensitivity with urticaria in someone on alendronate is quite rare. I am not aware of any publications showing another bisphosphonate safely used in this setting. Although there are significant chemical differences between the various oral and IV bisphosphonates, I personally would avoid the en...

How do you approach mild prolactin elevations (20-80) in women with galactorrhea on nipple stimulation but regular menses and no plans for pregnancy?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Kaiser Permanente Oakland Medical Center Endocrinology

I get baseline MRI of the sella and then monitor prolactin every 6-12 months. I don't treat unless the patient develops symptoms.

Is there a role for using continuous glucose monitors for perioperative glucose monitoring in patients with diabetes?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Brigham And Womens Hospital Endocrinology

Use of continuous glucose monitors is becoming more widely accepted for outpatients with diabetes to manage their glucose. Many hospitals now allow patients to continue to use their CGM when admitted, though most require some hospital monitoring as well. During the early phases of COVID, ICUs starti...

Should all kidney transplant patients be started on statin therapy post operatively given their increased risk of CVD?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Medical University of South Carolina College of Medicine

A kidney transplant is not an indication for statin therapy per se. The 2018 cholesterol guidelines list CKD (but not ESRD or Transplant) as a risk-enhancing factor. I would guide the decision to use statin therapy based on the patient's risk as assessed for non-transplant patients. Having said that...

Is thyrotropin receptor antibody a good biomarker to predict development of thyroid eye disease?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Kaiser Permanente Oakland Medical Center Endocrinology

Patients with thyroid eye disease usually have positive TRAb or TSI but in patients with Graves' hyperthyroidism it does not help predict the development of eye disease which is much less common than hyperthyroidism.

Do you recommend non-bypass bariatric surgeries over intestinal bypass procedures for kidney transplant-eligible candidates to prevent oxalate nephropathy, given the higher risk of kidney oxalate deposition with intestinal bypass?

1
2 Answers

Mednet Member
Mednet Member
Nephrology · University of Alabama Birmingham

Yes, my preference is for non-bypass bariatric surgery in my patients with severe obesity and sleeve gastrectomy is preferred. However, the GLP-1 agonists have really had an impact on weight loss in transplant patients and transplant candidates alike. There was a nice editorial by Lorden and Parajul...

Would you discontinue romosozumab in a patient who develops a hemorrhagic stroke while on therapy?

2
5 Answers

Mednet Member
Mednet Member
General Internal Medicine · University of New Mexico Health Sciences Center

Considering the boxed warning to stop Evenity in a patient who has a stroke or MI while receiving it, yes, I would stop it. It is the prudent thing to do. However, I know of no evidence of harm with continuing it, and I might consider continuing it if the balance of benefits and risks were overwhelm...

How do you manage osteoporosis treatment following parathyroidectomy for primary hyperparathyroidism?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · UC Davis

Good question and I usually do this with input from an endocrinologist. I monitor serum and urine calcium and provide supplements and if the bone mass declines, I consult an endocrinologist on the next steps. As a rheumatologist, I am not an expert on this issue.